Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis

NCT03018925 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Golimumab

Sponsor

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta